1.41
4.73%
-0.07
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Iterum Therapeutics' (ITRM) “Buy” Rating Reiterated at HC Wainwright - Defense World
Defense World
What Kind Of Investors Own Most Of Iterum Therapeutics plc (NASDAQ:ITRM)? - Yahoo Movies UK
Yahoo Movies UK
Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Q1 2024 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus.com
GuruFocus.com
Earnings call: Iterum Therapeutics reports Q1 2024 financials, updates on Sulopenem - Investing.com UK
Investing.com UK
Akoya Biosciences Reports First Quarter 2024 Financial Results - Yahoo Canada Finance
Yahoo Canada Finance
IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study - Yahoo Canada Finance
Yahoo Canada Finance
Iterum Therapeutics Reports First Quarter 2024 Financial Results - 13.05.2024 - wallstreet:online
wallstreet:online
Iterum Therapeutics (ITRM) to Release Quarterly Earnings on Monday - Defense World
Defense World
Iterum Therapeutics Announces CMO Transition and Consultant Role - TipRanks.com - TipRanks
TipRanks
Infectious disease index continues decline despite positive news - BioWorld Online
BioWorld Online
What Kind Of Investors Own Most Of Iterum Therapeutics plc (NASDAQ:ITRM)? - Yahoo Movies UK
Yahoo Movies UK
Pile Foundation Construction Service Industry Research Study |Menard Soltraitement, Keller Group, Bauer Group - Motions Online
Motions Online
3D Modeling Software for Game Market Emerging Trends | Autodesk, Unity, Adobe - Motions Online
Motions Online
Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 - EIN News
EIN News
What April's slowing job growth means for the Fed - Yahoo Canada Finance
Yahoo Canada Finance
Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
GlobeNewswire Inc.
Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer's Hemophilia B Gene ... - Pink Sheet
Pink Sheet
Iterum Therapeutics (NASDAQ:ITRM) vs. RedHill Biopharma (NASDAQ:RDHL) Head to Head Contrast - Defense World
Defense World
DIVIDEND 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share - Yahoo Canada Finance
Yahoo Canada Finance
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
GlobeNewswire Inc.
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
GlobeNewswire Inc.
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
Zacks Investment Research
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up - Yahoo Finance
Yahoo Finance
Sulopenem Etzadroxil/Probenecid Market Size and Share Analysis Across 7MM and Competitive Landscape by ... - openPR
openPR
BioWorld Infectious Disease Index closes 2023 down 43% - BioWorld Online
BioWorld Online
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC - Yahoo Finance
Yahoo Finance
Iterum reports positive results from Phase III trial of oral sulopenem - Clinical Trials Arena
Clinical Trials Arena
Why Iterum Therapeutics Stock Is Trending Today - Iterum Therapeutics (NASDAQ:ITRM) - Benzinga
Benzinga
United States Movie Market Analysis Report 2024-2030: Emerging Trends for Different Genders, Age Groups, Screen ... - Yahoo Finance UK
Yahoo Finance UK
Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3
Benzinga
Gas prices fell at a faster pace in Canadian cities this week, but one Ont. city sees double-digit drop - Yahoo Canada Finance
Yahoo Canada Finance
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89% - Yahoo Finance
Yahoo Finance
All You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buy - Yahoo Finance
Yahoo Finance
Cotações de Ações Americanas: Bolsas ao vivo e últimas notícias - Money Times
Money Times
UTIs: Why did you have to go and make things so complicated? - Contemporary Obgyn
Contemporary Obgyn
Pyelonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - GlobalData
GlobalData
Noelle honoured at Institute of Directors presentation - The Echo Newspaper
The Echo Newspaper
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players ... - GlobalData
GlobalData
As the world grows weary of COVID-19, so do infectious disease investors - BioWorld Online
BioWorld Online
63 Biggest Movers From Friday | Markets Insider - Markets Insider
Markets Insider
Cocrystal Pharmaceuticals Inc. (NASDAQ: COCP) Says Its COVID-19 Proteases Inhibitor CDI-45205 Effective Against ... - BP Journal
BP Journal
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical ... - Markets Insider
Markets Insider
FDA approvals drop as regulatory activity continues to climb - BioWorld Online
BioWorld Online
Hot Biotech Penny Stocks To Buy? 3 to Watch Right Now - Penny Stocks
Penny Stocks
Iterum Therapeutics (ITRM): Delayed Review Of Its NDA For Sulopenem, Upside Still Exists - Seeking Alpha
Seeking Alpha
Eyenovia Stock (NASDAQ:EYEN), Quotes and News Summary - Benzinga
Benzinga
Kapitalisierung:
|
Volumen (24h):